CSF2 and neoplasm: TAMs enhance PD-L1 expression via tumor-derived factors such as IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF), and hypoxia-induced hypoxia-inducible factor 1α (HIF-1α) signaling.